Promino Provides Update Respecting Private Placement

• The most recent release (April 22, 2026) provides an update on a previously announced non-brokered private placement for up to $1,200,000.
• The offering consists of 40,000,000 units priced at $0.03 per unit, including warrants exercisable at $0.06.
• Proceeds are designated for inventory production and general corporate purposes, excluding officer salaries and investor relations costs.
• A clarification was issued regarding the cancellation of 2 million common shares from treasury following a Helios Helium Corp acquisition cleanup in April 2026.
• Historical context shows a series of financing announcements since December 2025, including amendments to debenture offerings and private placements ranging from $1M to $1.72M.
• Operational updates indicate the company has reached approximately 10,000 retail doors in North America and launched its largest production run (3.5 million sticks) in March 2026.

• The financing update is incremental rather than transformative; it confirms progress on a deal announced in mid-March 2026.
• Capital raising of $1.2M supports inventory needs but does not alter the company's fundamental valuation or growth trajectory significantly compared to prior expectations.
• Share cancellation clarifies capital structure hygiene but has negligible impact on market cap given the small share count relative to total float implied by unit offerings.
• The news aligns with previous projections regarding production scale-up and distribution expansion, confirming management is executing on stated plans without deviation.
• No new strategic partnerships or revenue milestones were disclosed in this specific release that would warrant a material re-rating of the stock.

• Promino Nutritional Sciences Inc. focuses on functional beverage products under the Rejuvenate Muscle Health™ brand.
• Flagship product is a low-calorie (5 kcal), sugar-free, dairy-free amino-acid formulation designed for muscle preservation, particularly targeting consumers using GLP-1 weight-loss therapies.
• Distribution has expanded to approximately 10,000 retail locations across North America including pharmacy, grocery, and e-commerce channels like Amazon.
• The company recently launched an NCAA Division I athlete platform partnership with Virginia Military Institute (VMI) to validate product efficacy in a sports nutrition context.